ENDRA Life Sciences

General Information
We have commercialized an enhanced ultrasound technology for the pre-clinical research market and are leveraging that expertise to develop technology for increasing the capabilities of clinical diagnostic ultrasound to broaden patient access to the safe diagnosis and treatment of a number of significant medical conditions in circumstances where expensive X-ray computed tomography, or CT, and magnetic resonance imaging, or MRI, technology is unavailable or impractical. Since 2010, we have marketed and sold our Nexus 128 system, which combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications.
Employees: 8
Founded: 2007
Contact Information
Address ENDRA Life Sciences Inc. 3600 Green Court, Suite 350, Ann Arbor, MI 48105, US
Phone Number (734) 335-0468
Web Address https://www.endrainc.com
View Prospectus: ENDRA Life Sciences
Financial Information
Market Cap $18.2mil
Revenues $0.5 mil (last 12 months)
Net Income $-2.8 mil (last 12 months)
IPO Profile
Symbol NDRAU
Exchange NASDAQ
Shares (millions): 1.7
Price range $5.00 - $5.00
Est. $ Volume $8.4 mil
Manager / Joint Managers National Securities Corporation/ Dougherty & Company
CO-Managers -
Expected To Trade: 5/9/2017
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change